… Obtaining serial inflammatory markers in conjunction with anti-phospholipid antibody testing
revealed clinically significant Antiphospholipid syndrome (APS). This case series reviews …

… This manuscript will focus on the laboratory aspects, the clinical relevance of assays and …
persistently positive antiphospholipid antibodies (aPL). The clinical and laboratory diagnosis of …

… is not recommended as these antibodies have no added value in the diagnosis of APS. This
… , the clinical relevance of assays and interpretation of aPL results in the diagnosis of APS. …

… for the diagnosis but are also a risk factor for the antiphospholipid syndrome (APS)
clinical … but with doubtful clinical significance. A critical interpretation of the real diagnostic/prognostic …

… The use of antiphospholipid antibodies tests in the COVID-19 clinical setting needs to be
taken in context; whereas they are associated with more serve disease, they do not …

… for the development of the study’s clinical outcomes, such as arterial or venous thrombosis …
the antibodies at baseline screening. A repeat screening for all antibodies (anticardiolipin IgG/…

… diagnostic and clinical value of IgM antiphospholipid antibodies (… testing for aCL and aβ2GPI
IgM in women suspected of obstetric APS. However, no added value was found for testing …

… of tests, because the positivity of aCL detected by TLC-immunostaining is more prevalent
and aVim/CL is easier to perform and can add clinical value. The pattern of clinical features …

… as the clinical relevance of these antibodies is far from being … The relevance in clinical practice
of non-conventional APS … on Antiphospholipid Antibodies, in which each relevant clinical …

… clinical problem(s), eg provoked deep vein thrombosis (DVT) in a low titer single anticardiolipin
antibody (aCL) positive patient tested … that patients with clinically significant aPL-profiles …